Ondo InsurTech PLC
10 July 2026
Terms used but not defined in this announcement have the same meaning as set out in the Company's announcement released at 4:05 pm on 22 June 2026.
10 July 2026
Ondo InsurTech Plc
("Ondo" or the "Company")
Director/PDMR Dealings
Ondo InsurTech Plc (LSE: ONDO), a leading provider of claims prevention technology for home insurers, confirms that, following the completion of the Fundraising, the Directors of the Company have subscribed for a total of 5,316,104 New Ordinary Shares as set out below:
|
Director |
Number of New Ordinary Shares |
Resultant holding as at Admission |
% Enlarged Share Capital |
|
Gregory Mark Wood CBE |
1,999,049 |
4,533,701 |
1.8% |
|
Craig Foster |
988,639 |
3,514,239 |
1.4% |
|
Kevin Withington |
282,468 |
656,140 |
0.3% |
|
Graham Bird |
1,173,418 |
1,314,541 |
0.5% |
|
James Quin |
260,252 |
340,252 |
0.1% |
|
Greig Paterson |
612,278 |
692,278 |
0.3% |
The PDMR notification in respect of the Directors' participation, made in accordance with the requirements of UK MAR, is set out at the end of this announcement.
Enquiries
For further information, please visit www.ondoplc.com or contact the following:
|
Ondo InsurTech Plc |
Mark Wood, Executive Chairman Craig Foster, CEO Kevin Withington, CFO |
+44 (0) 800 783 9866 |
|
Singer Capital Markets (Broker & Financial Adviser) |
Charles Leigh-Pemberton Jen Boorer James Todd Anastassiya Eley |
+44 (0) 20 7496 3000 |
|
Alma Strategic Communications |
Andrew Jaques Andy Bryant Hannah Campbell |
+44 (0) 20 3405 0205 or ondo@almastrategic.com |
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
||||||||||||||||||||||
|
a) |
Name |
1) Gregory Mark Wood CBE 2) Craig Foster 3) Kevin Withington 4) Graham Bird 5) James Quin 6) Greig Paterson |
|||||||||||||||||||||
|
2 |
Reason for the notification |
||||||||||||||||||||||
|
a) |
Position/status |
1) Executive Director 2) Chief Executive Officer 3) Chief Financial Officer 4) Non-Executive Director 5) Non-Executive Director 6) Non-Executive Director |
|||||||||||||||||||||
|
b) |
Initial notification / Amendment |
Initial Notification |
|||||||||||||||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||||||||||||||||||
|
a) |
Name |
Ondo InsurTech Plc |
|||||||||||||||||||||
|
b) |
LEI |
2138005Y5QBJQMOOI719 |
|||||||||||||||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||||||||||||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 1 pence each ISIN: GB00BNVVGD77 |
|||||||||||||||||||||
|
b) |
Nature of the transaction |
Purchase of ordinary shares |
|||||||||||||||||||||
|
c) |
Price(s) and volume(s) |
|
|||||||||||||||||||||
|
d) |
Aggregated information |
N/A - each a single transaction |
|||||||||||||||||||||
|
e) |
Date of the transaction |
10 July 2026 |
|||||||||||||||||||||
|
f) |
Place of the transaction |
London Stock Exchange, Main Market (XLON) |
|||||||||||||||||||||
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.